Intuitive Surgical, Inc. $ISRG Shares Purchased by Sierra Summit Advisors LLC

Sierra Summit Advisors LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 24,303 shares of the medical equipment provider’s stock after acquiring an additional 1,300 shares during the period. Intuitive Surgical makes up approximately 1.7% of Sierra Summit Advisors LLC’s investment portfolio, making the stock its 23rd largest position. Sierra Summit Advisors LLC’s holdings in Intuitive Surgical were worth $10,869,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Vanguard Group Inc. lifted its position in Intuitive Surgical by 0.8% during the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after buying an additional 263,828 shares in the last quarter. State Street Corp raised its holdings in shares of Intuitive Surgical by 1.2% during the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock worth $8,451,223,000 after acquiring an additional 182,871 shares during the period. Geode Capital Management LLC boosted its position in shares of Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after acquiring an additional 109,904 shares during the last quarter. Norges Bank purchased a new stake in shares of Intuitive Surgical in the second quarter valued at about $2,569,260,000. Finally, Invesco Ltd. increased its position in Intuitive Surgical by 4.8% during the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock worth $2,402,488,000 after purchasing an additional 201,159 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.7%

ISRG opened at $503.51 on Friday. The stock’s 50-day moving average price is $529.83 and its 200 day moving average price is $511.71. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The firm has a market cap of $178.81 billion, a price-to-earnings ratio of 63.82, a PEG ratio of 3.88 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.21 earnings per share. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In related news, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president directly owned 660 shares of the company’s stock, valued at $326,673.60. The trade was a 16.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Mark Brosius sold 4,500 shares of the stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the sale, the senior vice president directly owned 907 shares in the company, valued at $496,455.52. This represents a 83.23% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 56,409 shares of company stock worth $30,895,377 over the last three months. 0.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ISRG. BTIG Research reissued a “buy” rating and issued a $616.00 price target on shares of Intuitive Surgical in a research note on Friday, January 23rd. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 19th. Sanford C. Bernstein raised their target price on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Argus lowered their price target on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Finally, Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $615.86.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.